BioNTech RNA Pharmaceuticals GmbH
GPTKB entity
Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:collaboratedWith |
gptkb:Pfizer
|
| gptkbp:country |
gptkb:Germany
|
| gptkbp:focus |
infectious diseases
immunotherapy mRNA therapeutics |
| gptkbp:founded |
2008
|
| gptkbp:foundedBy |
gptkb:Uğur_Şahin
gptkb:Özlem_Türeci gptkb:Christoph_Huber |
| gptkbp:headquarters_location |
gptkb:Mainz
|
| https://www.w3.org/2000/01/rdf-schema#label |
BioNTech RNA Pharmaceuticals GmbH
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:legalForm |
gptkb:company
|
| gptkbp:notableProduct |
gptkb:BNT162b2_COVID-19_vaccine
|
| gptkbp:parentOrganization |
gptkb:BioNTech_SE
|
| gptkbp:website |
https://biontech.de/
|
| gptkbp:bfsParent |
gptkb:BioNTech
|
| gptkbp:bfsLayer |
5
|